Dr. Sunny Sharma, is a Senior Managing Director, Asia. Dr. Sharma has more than a dozen years of life sciences experience spanning venture capital, investment banking, and clinical practice. Dr. Sharma was previously with Investor Growth Capital (IGC), the wholly owned global venture capital arm of Investor AB, and before that with Easton Capital, a venture capital fund in New York. While at IGC and Easton Capital, Dr. Sharma led or played a senior role on over a dozen life sciences investments. Earlier in his career, Dr. Sharma was with Lehman Brothers' healthcare investment banking group in London, and before that he practiced medicine in northern India. Dr. Sharma holds an M.B.A. from Indian Institute of Management, Bangalore and a medical degree (M.B.B.S.) from Christian Medical College, Ludhiana where he was awarded the Vipin Khanna Memorial Gold Medal for graduating as the best intern.

Back to Top

Dr. David Wang is a Senior Managing Director, Asia. Most recently, Dr. Wang was a Managing Director at WI Harper Group, responsible for healthcare investment in China. Previously, he served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging. Dr. Wang was co-founder and Executive Vice President at First Genetic Trust, a personalized medicine company. During his tenure at Bristol-Myers Squibb, Dr. David Wang was Chairman of The SNP Consortium Management Committee where he was responsible for strategy and management of the consortium. The SNP Consortium is the first group of its kind formed by pharmaceutical and technology industries as well as academia and charities to support the development of personalized medicine. Dr. David Wang received his M.D. from Peking University Medical School. He earned his doctorate in Developmental Biology from California Institute of Technology.

Back to Top

Rajesh Dalal is a Venture Partner on the Asia team. Prior to joining OrbiMed, Mr. Dalal spent more than 30 years with Johnson and Johnson (J&J) in Asia including the past five years as the head of M&A for J&J Medical in the Asia Pacific Region. In this role, he worked closely with scores of medical device companies in China, India and other parts of Asia. Mr. Dalal was previously the Managing Director of J&J Medical, India for six years with overall responsibility for the medical device businesses at Cordis, DePuy, Endo, Lifescan, Ethicon and Hospital Supplies. A native of Mumbai, Mr. Dalal is a mechanical engineer from the prestigious IIT Madras, and holds an M.B.A. from Bajaj Institute, Bombay.

Back to Top

Dr. Hongbo Lu is an Executive Director, Asia at OrbiMed. Previously, Dr. Lu spent more than five years at Piper Jaffray & Co as an equity analyst. She led Piper's China healthcare research team and was instrumental in building the firm's brand in the Asian marketplace. Prior to her Wall Street career, Dr. Lu spent four years in life science start-up operations and business development at Zyomyx, Inc. Dr. Lu received a Ph.D. in BioEngineering from the University of Washington, an M.B.A. from the Haas School of Business at the University of California, Berkeley, and a B.S./M.S. in Materials Science and Engineering from Tsinghua University in China.

Back to Top

Swati Bansal is a Senior Associate on the Asia team. Prior to joining OrbiMed, she worked as a Global Healthcare Analyst in the proprietary equity division at DSP Merrill Lynch in Mumbai, and was responsible for spearheading a portfolio of Asian healthcare stocks. Previously, Swati was a Senior Analyst at Genpact where she earned the prestigious Silver Award in 2007, and before that she started her career as a Research Analyst at Irevna Research, a Standard & Poors' company. Swati received her CFA Charter and M.B.A. from ICFAI University, Hyderabad. She also holds an Engineering degree (B.E.) in Medical Electronics from BMS College of Engineering, Bangalore.

Back to Top

Jonathan Chong Wang is a Senior Associate based in the Shanghai office. Prior to joining OrbiMed, he worked as a consultant at the Boston Consulting Group, focused on healthcare projects for both multinationals and local China companies. Previously, Jonathan worked in the Goldman Sachs investment banking division and Burrill Venture Capital in San Francisco. A native of Shanghai, Jonathan received an M.B.A. in Healthcare Management from The Wharton School at the University of Pennsylvania. He also has a B.S. in Actuarial Science and Mathematics from the University of New South Wales in Australia.

Back to Top

Trency Gu, Ph.D., is an Associate on the OrbiMed Asia team. Prior to joining OrbiMed, Dr. Gu worked as a Project Manager at Eli Lilly Global External Research and Development Department in Shanghai, where she was responsible for the collaborations, partnering and office operational activities. Prior, she was Associate Director for Development Planning at Shanghai Genomics, a biotech company focused on drug discovery and development. There, she managed in-licensing activities and IND-enabling studies for NCE development. A native of Shanghai, Dr. Gu has a B.S. with double majors in Biotechnology and English, and a Ph.D. in Biochemistry and Molecular Biology, both from Shanghai Jiaotong University.

Back to Top

Vikram Popli, M.B.B.S., MS (Orthopedics), is an Associate on the Asia team. Prior to joining OrbiMed, he worked as a Senior Business Analyst with Bristol Myers Squibb in Mumbai where he was responsible for diligence and financial analysis of various business development opportunities. Dr. Popli graduated from the prestigious Maulana Azad Medical College in Delhi and specialized in Orthopedic Surgery at Safdarjang Hospital. He also has an MBA in finance from the Indian School of Business, Hyderabad.

Back to Top